Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Adrenal cortex carcinoma was added as a lay term for Adrenocortical Carcinoma in the Conditions section.
    Difference
    0.0%
    Check dated 2026-03-27T21:52:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T19:36:23.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; the page now shows Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:46:06.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.4.2, replacing Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T11:52:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A minor revision update was added (Revision: v3.4.1) and the previous revision (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:30:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Glossary visibility was added and QC metadata/revision text updated; these are display-only changes and do not modify study content.
    Difference
    0.2%
    Check dated 2026-01-29T06:53:00.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.